{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:28:17Z","timestamp":1787653697986,"version":"build-2736575974"},"reference-count":31,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Respir Dis"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chronic cough, a cough lasting &gt;8\u2009weeks, includes refractory chronic cough (RCC) and unexplained chronic cough (UCC). Patient-reported outcome (PRO) measures are needed to better understand chronic cough impacts that matter most to patients. The 19-item Leicester Cough Questionnaire (LCQ), an existing PRO measure of chronic cough, assesses impacts of cough across physical, psychological, and social domains. However, the content validity of the LCQ evaluating these concepts in patients with RCC\/UCC had not been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate the content validity of the LCQ in patients with RCC\/UCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A cross-sectional, qualitative interview study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>First, previously completed qualitative interview results in adults with RCC\/UCC ( N\u2009=\u200930) were evaluated and mapped to LCQ concepts. Next, a clinical cough expert reviewed each LCQ item and assessed the salience of its concepts for patients with RCC\/UCC. Finally, semistructured interviews\u2014including both concept elicitation and cognitive debriefing\u2014were conducted in adults with RCC\/UCC ( N\u2009=\u200920) to elicit a comprehensive set of participant experiences and to assess the appropriateness of using the LCQ in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Concepts reported in the past and present qualitative interviews were included across all LCQ items, and most impacts reported to be the \u201cmost bothersome\u201d were assessed in the LCQ. In the current study, all participants indicated that reduced cough frequency would be an important treatment target. During cognitive debriefing, each LCQ item was endorsed by \u2a7e70% of participants. Additionally, participants were generally able to understand, recall, and select a response for each LCQ item. All participants and the clinical expert indicated that the LCQ was appropriate and assessed the impacts most relevant to patients with RCC\/UCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings support the content validity of the LCQ and demonstrate that this measure is fit-for-purpose and includes important cough impacts in adults with RCC\/UCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17534666241274261","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:43:34Z","timestamp":1725669814000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6385-5570","authenticated-orcid":false,"given":"Allison","family":"Martin Nguyen","sequence":"first","affiliation":[{"name":"Merck & Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"La Rosa","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra G.","family":"Cornell","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandel R.","family":"Sher","sequence":"additional","affiliation":[{"name":"Center for Cough, Largo, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, OH, USA"},{"name":"Bernstein Clinical Research Center, LLC, Cincinnati, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder S.","family":"Birring","sequence":"additional","affiliation":[{"name":"Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"(DeMuro) Romano","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Mayorga","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirline","family":"Milien","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2546-8980","authenticated-orcid":false,"given":"Claire","family":"Ervin","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, 3040 E. Cornwallis Rd., Research Triangle Park, NC 27709-2194, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"bibr1-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00218714"},{"key":"bibr2-17534666241274261","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-22-1435"},{"key":"bibr3-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0104-2021"},{"key":"bibr4-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.1_suppl.1S"},{"key":"bibr5-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-1496"},{"key":"bibr6-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.4.339"},{"key":"bibr7-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1186\/1745-9974-2-4"},{"key":"bibr8-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30150-4"},{"key":"bibr9-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-007-9034-x"},{"key":"bibr10-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1177\/1359105316684204"},{"key":"bibr11-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-015-9701-2"},{"key":"bibr12-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.6.1839"},{"key":"bibr13-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.15.1657"},{"key":"bibr14-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1177\/17534666241236025"},{"key":"bibr15-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02348-5"},{"key":"bibr16-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2003"},{"key":"bibr17-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1177\/17534666221099737"},{"key":"bibr18-17534666241274261","volume":"6","author":"Spinou A","year":"2014","journal-title":"J Thorac Dis"},{"key":"bibr19-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-79842-2_16"},{"key":"bibr20-17534666241274261","unstructured":"Food and Drug Administration (FDA). Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. December 2009. https:\/\/www.fda.gov\/media\/77832\/download (accessed 8 August 2023)."},{"key":"bibr21-17534666241274261","unstructured":"Food and Drug Administration (FDA). Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments. Guidance for industry, Food and Drug Administration staff, and other stakeholders. Draft guidance. https:\/\/www.fda.gov\/media\/159500\/download (2022, accessed 8 August 2023)."},{"key":"bibr22-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"bibr23-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.11.014"},{"key":"bibr24-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-02069-w"},{"key":"bibr25-17534666241274261","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.654797"},{"key":"bibr26-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-2506"},{"key":"bibr27-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.133868"},{"key":"bibr28-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.4.1123"},{"key":"bibr29-17534666241274261","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.09.62"},{"key":"bibr30-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X05279903"},{"key":"bibr31-17534666241274261","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232076"}],"container-title":["Therapeutic Advances in Respiratory Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666241274261","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17534666241274261","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666241274261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T01:27:28Z","timestamp":1740965248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17534666241274261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"alternative-id":["10.1177\/17534666241274261"],"URL":"https:\/\/doi.org\/10.1177\/17534666241274261","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/17534666241274261\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666241274261\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666241274261\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666241274261\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666241274261\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1753-4666","1753-4666"],"issn-type":[{"value":"1753-4666","type":"print"},{"value":"1753-4666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"article-number":"17534666241274261"}}